|
Volumn 20, Issue 12, 2014, Pages 1013-1014
|
Blood-brain barrier is not a barrier in the development of new drugs for ischemic stroke
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANISODAMINE;
ANTICOAGULANT AGENT;
ANTITHROMBOCYTIC AGENT;
FIBRINOLYTIC AGENT;
METHYLXANTHINE DERIVATIVE;
NEOSTIGMINE;
NEUROPROTECTIVE AGENT;
NEW DRUG;
PENTIFYLLINE;
PENTOXIFYLLINE;
PROPENTOFYLLINE;
VASODILATOR AGENT;
ARTERIOLE;
BLOOD BRAIN BARRIER;
BLOOD VISCOSITY;
BRAIN BLOOD FLOW;
BRAIN BLOOD VESSEL;
BRAIN INFARCTION;
BRAIN INFARCTION SIZE;
BRAIN ISCHEMIA;
CLINICAL TRIAL (TOPIC);
COLLATERAL CIRCULATION;
DRUG EFFICACY;
DRUG PENETRATION;
DRUG SAFETY;
EDITORIAL;
ERYTHROCYTE;
HUMAN;
MEMBRANE PERMEABILITY;
NEUROPROTECTION;
STROKE PATIENT;
THROMBOCYTE AGGREGATION INHIBITION;
VASODILATATION;
COMPLICATION;
DRUG DEVELOPMENT;
DRUG EFFECTS;
PATHOLOGY;
PHYSIOLOGY;
PROCEDURES;
STROKE;
BLOOD-BRAIN BARRIER;
BRAIN ISCHEMIA;
DRUG DISCOVERY;
HUMANS;
STROKE;
|
EID: 84911367979
PISSN: 17555930
EISSN: 17555949
Source Type: Journal
DOI: 10.1111/cns.12356 Document Type: Editorial |
Times cited : (5)
|
References (8)
|